Home
Health A to Z
Health A to Z
Health A to Z
Allergies
Alternative Medicine
Asthma
Blood Disorders
Bone and Joint
Cancer
Cardiovascular Diseases
Caregiving
Child Health
Coronavirus
Cosmetic
Dental Care
Diabetes
Digestive System
Disabilities
Drug Center
Ear, Nose, and Throat
Environmental Health
Exercise And Fitness
Eye Care
Fertility
First Aid and Emergencies
General Health
Health Technology
Hearing Loss
Hypertension
Infectious Disease
LGBTQ Health
Liver Health
Men's Health
Mental Health
Neurology
Nutrition
Pain Management
Pets
Pregnancy
Public Health
Pulmonology
Senior Health
Sexual Health
Skin Health
Stroke
Weight Loss
Women's Health
News For Medical Professionals
Video
Content Licensing
Content Licensing
Our Products
Consumer News
Physician's Briefing
HealthDay TV
Wellness Library
HealthDay Living
Conference Coverage
Conference Coverage Schedule
Single story licensing
Custom Content
Custom Content
Custom Products
Health Writing
Health Editing
Video Production
Sponsored Microsite
HCP Specialty Newsletters
About
About
About Us
Editorial Policy
Medical Review
Contact Us
Subscribe
Spanish
Newsletter
Immunotherapy
Cancer
Cretostimogene Promising for High-Risk, Non-Muscle-Invasive Bladder Cancer
Elana Gotkine
Aug 06, 2026
1 min read
Allergies
Omalizumab, Multiallergen OIT Both Viable for Multifood Allergy Treatment
Elana Gotkine
Aug 03, 2026
2 min read
Cancer
Enfortumab Vedotin-Pembrolizumab More Effective for MIBC Than Cisplatin-Gemcitabine
Elana Gotkine
Jul 28, 2026
2 min read
Cancer
Indefinite-Duration Maintenance Therapy No Better Than Fixed-Duration Therapy in Multiple Myeloma
Elana Gotkine
Jul 23, 2026
1 min read
Neurology
Rituximab Noninferior to Ocrelizumab for Newly Diagnosed Relapsing MS
Elana Gotkine
Jul 06, 2026
1 min read
Cancer
Aglatimagene Besadenovec + Valacyclovir Ups DFS in Localized Prostate Cancer
Elana Gotkine
Jun 12, 2026
2 min read
Allergies
Feeding Babies Eggs Sooner May Cut Allergy Risk, Study Suggests
Dennis Thompson
Jun 09, 2026
3 min read
Cancer
Chemo-Free Drug Shows Major Survival, Remission Gains In Relapsed Multiple Myeloma
Dennis Thompson
Jun 03, 2026
2 min read
Cancer
ASCO: Teclistamab Improves Survival in Relapsed, Refractory Multiple Myeloma
Elana Gotkine
Jun 02, 2026
2 min read
Read More
www.healthday.com
INSTALL APP